Trevi Therapeutics, Inc. (TRVI)
13.51
0.00 (0.00%)
USD |
NASDAQ |
Nov 18, 16:00
13.54
+0.02
(+0.19%)
After-Hours: 20:00
Trevi Therapeutics Price : 13.51 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 13.39 | 13.96 | 13.29 | 13.51 | 2.066M |
| Nov 17, 2026 | 13.61 | 13.61 | 12.89 | 13.51 | 1.729M |
| Nov 16, 2026 | 13.53 | 13.67 | 13.14 | 13.29 | 1.665M |
| Nov 13, 2026 | 13.57 | 14.17 | 13.17 | 13.65 | 1.100M |
| Nov 12, 2026 | 14.51 | 14.60 | 13.11 | 13.62 | 2.015M |
| Nov 11, 2026 | 15.00 | 15.12 | 14.48 | 14.82 | 1.522M |
| Nov 10, 2026 | 14.12 | 15.25 | 13.64 | 14.91 | 2.323M |
| Nov 09, 2026 | 14.59 | 15.48 | 14.33 | 15.31 | 1.444M |
| Nov 06, 2026 | 13.04 | 14.36 | 13.00 | 14.33 | 2.549M |
| Nov 05, 2026 | 14.01 | 14.01 | 12.79 | 12.81 | 1.584M |
| Nov 04, 2026 | 14.35 | 14.52 | 13.48 | 13.98 | 1.380M |
| Nov 03, 2026 | 13.81 | 14.23 | 13.74 | 13.86 | 1.191M |
| Nov 02, 2026 | 13.70 | 13.80 | 13.21 | 13.63 | 1.472M |
| Oct 30, 2026 | 13.52 | 13.91 | 13.44 | 13.56 | 1.732M |
| Oct 29, 2026 | 13.65 | 14.06 | 13.46 | 13.81 | 1.345M |
| Oct 28, 2026 | 13.26 | 13.54 | 13.21 | 13.52 | 1.066M |
| Oct 27, 2026 | 12.63 | 13.44 | 12.50 | 13.35 | 2.100M |
| Oct 26, 2026 | 12.65 | 12.93 | 12.34 | 12.51 | 979097.0 |
| Oct 23, 2026 | 12.74 | 12.74 | 12.39 | 12.61 | 1.377M |
| Oct 22, 2026 | 12.77 | 13.22 | 12.53 | 12.94 | 1.185M |
| Oct 21, 2026 | 12.77 | 13.30 | 12.72 | 12.77 | 2.651M |
| Oct 20, 2026 | 12.11 | 13.11 | 11.93 | 12.83 | 1.828M |
| Oct 19, 2026 | 12.00 | 12.22 | 11.74 | 11.90 | 1.598M |
| Oct 16, 2026 | 12.08 | 12.08 | 11.70 | 11.88 | 2.719M |
| Oct 15, 2026 | 12.06 | 12.38 | 11.98 | 12.11 | 1.709M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 71.47 |
| Corcept Therapeutics, Inc. | 67.79 |
| Veru, Inc. | 2.31 |
| Johnson & Johnson | 272.70 |
| Eli Lilly & Co. | 1382.75 |
Price Related Metrics
| PEG Ratio | -5.196 |
| Price to Book Value | 6.360 |
| Earnings Yield | -2.93% |
| Market Cap | 1.926B |
| PEGY Ratio | -5.196 |